Explore the Tracks Powering BioProcess International (BPI) West

Discover how BPI West is revolutionizing bioprocessing by bringing together industry leaders and innovators to tackle the challenges of developing, scaling, and manufacturing therapies faster, smarter, and more sustainably.

Where bioprocessing innovation meets real-world execution

BPI West brings together the brightest minds in biologics and advanced therapies to tackle one shared challenge: how do we develop, scale, and manufacture better therapies faster, smarter, and more sustainably?

Whether you’re optimizing cell lines, rethinking manufacturing strategy, or commercializing next-generation modalities, BPI West’s multi-track agenda is designed to meet you where you are and take you further.

Below is a track-by-track guide to what each stream is about, who it’s for, and the must-see sessions shaping the future of bioprocessing.

Cell Line Development & Engineering

Build stronger foundations for every downstream decision

The race for more effective biologics begins with the cell. In recent years, cell line development (CLD) has undergone a transformation: companies are leveraging high-throughput screening, AI-guided selection, and gene-editing technologies to design lines that are faster, more productive, and more stable than ever before. With pressure to move therapies into the clinic quickly, the decisions made at this stage can make or break development timelines and product quality.

This track dives into how modern CLD strategies are reshaping biologics pipelines, from small molecules to complex multimodal proteins. Attendees will explore innovations in automation, predictive modelling, and high-performance cell engineering, all aimed at achieving robust, scalable production early in the development process.

What CLD strategies questions will this track cover?

How can I reduce development timelines without increasing risk?
What factors improve predictability and performance early in the cell live development lifecycle?
How to align CLD decisions with downstream and commercial goals effectively?

Sessions to watch:

Best for: CLD scientists, early-stage development teams, platform strategy leaders

Cell Culture & Upstream Processing

Optimize productivity, control complexity, and scale with confidence

Upstream processing is evolving faster than ever. The need for higher yields, consistent quality, and faster scale-up has accelerated innovations in bioreactor design, process intensification, and digital monitoring. Companies are increasingly using real-time analytics, predictive modelling, and machine learning to maintain control over complex biological systems while scaling efficiently.

This track explores the frontlines of upstream innovation: how scientists are pushing the boundaries of cell culture performance, mitigating variability, and implementing strategies that support both speed and reproducibility. Attendees will gain insights into digital process control, media optimization, and advanced sensor technologies that are shaping the next generation of biologics manufacturing.

What upstream processing and cell culture questions will this track address?

How can I increase yields while protecting product quality?
How to effectively apply AI and advanced analytics to real-world upstream challenges?
How can I design scalable, resilient processes from lab to manufacturing?

Sessions to watch:

Best for: Upstream scientists, process engineers, MSAT teams

Manufacturing Strategy & Bioprocessing 4.0

Transform operations with digital, data-driven manufacturing

Manufacturing is no longer just about producing batches; it’s about creating agile, intelligent, and predictive facilities. Bioprocessing 4.0 integrates digital twins, predictive analytics, and automation to improve efficiency, reduce errors, and accelerate decision-making. As regulatory expectations rise and multi-product facilities become the norm, organizations need to rethink not only processes but also strategies for facility design, workforce upskilling, and operational resilience.

This track addresses the strategic transformation of manufacturing operations, highlighting real-world examples of how digital tools are enabling smarter decisions, greater flexibility, and faster responses to market demands. Attendees will leave with a roadmap for integrating digital solutions and future-proofing their operations.

What manufacturing questions will this track answer?

How are big biotech/pharma deploying Bioprocessing 4.0?
What are digital twins and how can they support quality, speed, and scale?
How can I bridge the gap between data strategy and operational impact?

Sessions to watch:

Best for: Manufacturing leaders, digital transformation teams, operations strategy professionals

Recovery & Purification

Remove downstream bottlenecks and unlock efficiency

Downstream processing is at a tipping point. While upstream productivity is increasing, purification processes must keep pace to avoid bottlenecks. Advances in continuous chromatography, integrated DSP trains, and platform purification strategies are helping manufacturers produce high-purity biologics faster and more cost-effectively.

This track explores how the latest innovations in recovery and purification can accelerate timelines, improve yields, and reduce manufacturing risk. Sessions will focus on scalable purification strategies for complex molecules, continuous process design, and quality-driven DSP optimization which is critical for companies scaling new modalities and high-value therapeutics.

What questions will this track answer to help you unlock efficiency with your downstream processes?

How can I eliminate my downstream bottlenecks?
What are the best strategies to improve throughput and process robustness?
How can I effectively prepare DSP strategies for next-generation biologics?

Sessions to watch:

Best for: Downstream scientists, purification experts, process development teams

Cell & Gene Therapy Production & Commercialization

Turn breakthrough science into accessible therapies

Cell and gene therapies are revolutionizing medicine, but manufacturing these advanced therapies presents unique challenges in scalability, supply chain logistics, and regulatory compliance. The field is evolving rapidly, with innovations in viral vector production, gene editing, and closed-system manufacturing enabling faster, more reliable delivery of transformative treatments.

This track highlights real-world strategies for scaling advanced therapies from clinical proof-of-concept to commercial launch. Sessions explore operational hurdles, regulatory pathways, and lessons from the frontlines, offering practical guidance to accelerate patient access while maintaining safety and quality.

What cell and gene production/commercialization questions will this track answer?

How can I scale complex, patient-centric therapies cost-effectively?
How to navigate manufacturing and data integrity challenges
What steps should I take to prepare for commercialization earlier and more effectively?

Sessions to watch:

Keynote: Cell & Gene Therapy at an Inflection Point
Data Integrity in Advanced Therapy R&D
AAV Commercialization Case Study: Lessons from the Field

Best for: CGT developers, viral vector specialists, commercialization and CMC leaders

Pre-Conference Workshops

Go deeper before the main event begins

BPI West’s pre-conference workshops offer hands-on, interactive learning for attendees who want to sharpen specific skills and apply new approaches immediately. From digital twin creation to continuous processing workflows, these workshops help you gain practical skills, ask questions, and leave ready to implement innovations.

Featured workshops include:

Ideal for: Teams looking for practical tools, not just theory

Explore the full agenda here